MAST1 drives cisplatin resistance in human cancers by rewiring cRaf-independent MEK activation

Jin, Lingtao, Chun, Jaemoo, Pan, Chaoyun, Li, Dan, Lin, Ruiting, Alesi, Gina N., Wang, Xu, Kang, Hee-Bum +18 more·2018·Cancer Cell
DOI 10.1016/j.ccell.2018.06.012

Cited by (134)

Items 101–134 of 134

  1. Monotherapy cancer drug-blind response prediction is limited to intraclass generalization
    William G. Herbert, Nicholas Chia, Paul A. Jensen, Marina R. S. Walther-Antonio · 2026 · PLoS Computational Biology
  2. CuET inhibits Ewing sarcoma of bone progression through modulation of the ESM1-MAPK/ERK signaling axis
    Wantong Xu, Zhongbiao Jiang, D Peng · 2026 · International Immunopharmacology
  3. RHCG-Upregulating Polymeric Nanoparticles for Sensitized Chemotherapy and Immunotherapy in Head and Neck Squamous Cell Carcinoma
    Huihui Zou, Zheng Wei, Wenguang Xu, Xinyu Zhang, Jianchuan Ran, Guorong Zhang, Zichen Cao, Tao Liu, Meng Zhou, Wei Han · 2023 · ACS Applied Nano Materials
  4. 3-deazaadenosine: A promising novel p38γ antagonist with potential as a breast cancer therapeutic agent
    Pradeep Natarajan, Manne Munikumar, Swetha Kumari Koduru, Teja Sree Bokkasam · 2023 · Cancer Treatment and Research Communications
  5. Synthetic lethality with cisplatin
    Leslie K. Ferrarelli · 2018 · Science Signaling
  6. PBA2, a novel compound, enhances radiosensitivity in various carcinoma cells by activating the p53 pathway in vitro and in vivo
    Shaobo Liang, Fang Wang, Min Luo, Hong Zhang, Shao-Cong Wu, Zhen Chen, Liwu Fu · 2020 · Free Radical Biology and Medicine
  7. NNAL, a major metabolite of tobacco-specific carcinogen NNK, promotes lung cancer progression through deactivating LKB1 in an isomer-dependent manner
    Tengfei Bian, Yuzhi Wang, Jordy F. Botello, Qi Hu, Yunhan Jiang, Adriana Zingone, Pedro A. Corral, Fatima Zahra Aly, Yougen Wu, Bríd M. Ryan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  8. Construction and validation of a prognostic risk model for uterine corpus endometrial carcinoma based on alternative splicing events*
    Yi Cheng, Long Li, Gong Chen, Kai Qin · 2022 · Oncology and Translational Medicine
  9. Inhibition of epigenetic and cell cycle-related targets in glioblastoma cell lines: onametostat reduces proliferation and viability in both normoxic and hypoxic conditions
    Darja Lavõgina, Mattias Kaspar Krõlov, Hans Vellama, Vijayachitra Modhukur, Valentina Di Nisio, Helen Lust, Kattri‐Liis Eskla, Andres Salumets, Jana Jaal · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Utilising Genetic Interaction Networks to Elucidate the Anticancer and Diabetogenic Activities
    Centya del Rio Hernandez · 2024
  11. Protein subinteractomes of human microsomal cytochromes P450
    Pavel V. Ershov, Evgeniy O. Yablokov, Yuri V. Mezentsev, Alexis S. Ivanov · 2025 · Molecular Biology Reports
  12. Additional file 7 of CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination
    Yunshu Zhu, Liang, Leilei, Zhao, Yuxi, Li, Jian, Zeng, Jia, Yuan, Yihang, N. Li, Lingying Wu · 2024 · Figshare
  13. Additional file 10 of CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination
    Yunshu Zhu, Liang, Leilei, Zhao, Yuxi, Li, Jian, Zeng, Jia, Yuan, Yihang, N. Li, Lingying Wu · 2024 · Figshare
  14. Additional file 4 of Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma
    Tao, Xingyu, Li, Yang, Fan, Songqing, Wu, Liyang, Jianyang Xin, Su, Yun, Xiaoyang Xian, Huang, Yingying, Huang, Rongquan, Fang, Weiyi et al. · 2024 · Figshare
  15. Additional file 6 of Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma
    Tao, Xingyu, Li, Yang, Fan, Songqing, Wu, Liyang, Jianyang Xin, Su, Yun, Xiaoyang Xian, Huang, Yingying, Huang, Rongquan, Fang, Weiyi et al. · 2024 · Figshare
  16. Additional file 4 of CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination
    Yunshu Zhu, Liang, Leilei, Zhao, Yuxi, Li, Jian, Zeng, Jia, Yuan, Yihang, N. Li, Lingying Wu · 2024 · Figshare
  17. Additional file 7 of Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma
    Tao, Xingyu, Li, Yang, Fan, Songqing, Wu, Liyang, Jianyang Xin, Su, Yun, Xiaoyang Xian, Huang, Yingying, Huang, Rongquan, Fang, Weiyi et al. · 2024 · Figshare
  18. Additional file 5 of Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma
    Tao, Xingyu, Li, Yang, Fan, Songqing, Wu, Liyang, Jianyang Xin, Su, Yun, Xiaoyang Xian, Huang, Yingying, Huang, Rongquan, Fang, Weiyi et al. · 2024 · Figshare
  19. Additional file 2 of CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination
    Yunshu Zhu, Liang, Leilei, Zhao, Yuxi, Li, Jian, Zeng, Jia, Yuan, Yihang, N. Li, Lingying Wu · 2024 · Figshare
  20. Additional file 8 of Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma
    Tao, Xingyu, Li, Yang, Fan, Songqing, Wu, Liyang, Jianyang Xin, Su, Yun, Xiaoyang Xian, Huang, Yingying, Huang, Rongquan, Fang, Weiyi et al. · 2024 · Figshare
  21. Additional file 9 of Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma
    Tao, Xingyu, Li, Yang, Fan, Songqing, Wu, Liyang, Jianyang Xin, Su, Yun, Xiaoyang Xian, Huang, Yingying, Huang, Rongquan, Fang, Weiyi et al. · 2024 · Figshare
  22. Additional file 5 of CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination
    Yunshu Zhu, Liang, Leilei, Zhao, Yuxi, Li, Jian, Zeng, Jia, Yuan, Yihang, N. Li, Lingying Wu · 2024 · Figshare
  23. Additional file 8 of CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination
    Yunshu Zhu, Liang, Leilei, Yuxi Zhao, Li, Jian, Zeng, Jia, Yuan, Yihang, N. Li, Lingying Wu · 2024 · Figshare
  24. Additional file 3 of Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma
    Tao, Xingyu, Li, Yang, Fan, Songqing, Wu, Liyang, Jianyang Xin, Su, Yun, Xiaoyang Xian, Huang, Yingying, Huang, Rongquan, Fang, Weiyi et al. · 2024 · Figshare
  25. Additional file 2 of Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma
    Tao, Xingyu, Li, Yang, Fan, Songqing, Wu, Liyang, Jianyang Xin, Su, Yun, Xiaoyang Xian, Huang, Yingying, Huang, Rongquan, Fang, Weiyi et al. · 2024 · Figshare
  26. Additional file 1 of Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer
    Mao, Xiao-hong, Ye, Qiang, Zhang, Guo-bing, Jiang, Jin-ying, Zhao, Hong-ying, Shao, Yan-fei, Ye, Zi-qi, Xuan, Zi-xue, Huang, Ping · 2021 · Figshare
  27. Additional file 1 of Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma
    Tao, Xingyu, Li, Yang, Fan, Songqing, Wu, Liyang, Jianyang Xin, Su, Yun, Xiaoyang Xian, Huang, Yingying, Huang, Rongquan, Fang, Weiyi et al. · 2024 · Figshare
  28. Additional file 9 of CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination
    Yunshu Zhu, Liang, Leilei, Zhao, Yuxi, Li, Jian, Zeng, Jia, Yuan, Yihang, N. Li, Wu, Lingying · 2024 · Figshare
  29. Additional file 3 of CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination
    Yunshu Zhu, Liang, Leilei, Zhao, Yuxi, Li, Jian, Zeng, Jia, Yuan, Yihang, N. Li, Lingying Wu · 2024 · Figshare
  30. Additional file 6 of CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination
    Yunshu Zhu, Liang, Leilei, Zhao, Yuxi, Li, Jian, Zeng, Jia, Yuan, Yihang, N. Li, Lingying Wu · 2024 · Figshare
  31. Additional file 1 of CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination
    Yunshu Zhu, Liang, Leilei, Zhao, Yuxi, Li, Jian, Zeng, Jia, Yuan, Yihang, N. Li, Lingying Wu · 2024 · Figshare
  32. PRMT1 facilitates the tumorigenesis of chronic lymphocytic leukemia by regulating methylation of MAST1
    Z. B. Tian, Pan Gao, Yang Zhang, Jun Ma, Xinting Hu, Hua Wang, Liyan Lu, Ya Zhang, Xin Wang · 2026 · Leukemia
  33. The Five-Decade Journey of Small Cell Lung Cancer
    Runzhi Chen, Chang Xue, Yi Zhong, Qing Huang, Qianyu Fan, Yuanxiang Li, Jingyi Wu, Shuang Dong, Xiaoyu Li, Tianlin Xiao et al. · 2026 · 癌症：英文版
  34. A complex of MAST1 and 14-3-3η regulates Tau phosphorylation in the developing cortex
    Sumire Antonioli, Patrick Heisterkamp, Weiqiang Chen, Dorothea Anrather, Markus Hartl, María Fernanda Martínez-Reza, Ratna Tripathy, Michael Schutzbier, Karl Mechtler, David A. Keays et al. · 2026 · Proceedings of the National Academy of Sciences